Literature DB >> 29218098

Overexpression of microRNA-145 protects against rat myocardial infarction through targeting PDCD4.

Hao Xu1, Heng Cao1, Guoqing Zhu2, Shaowen Liu1, Hongli Li1.   

Abstract

Myocardial infarction (MI) is a common cardiovascular disease with high mortality. The aim of the present study was to determine the biological role of miR-145 in MI rats and hypoxia-injured cardiomyocytes and to elucidate the potential mechanism. MI rats were induced by left anterior descending artery (LAD) ligation. qRT-PCR and western blot analysis were performed to determine the mRNA and protein levels, respectively. Compared with sham group, miR-145 levels in MI group were significantly decreased. We observed that lentivirus-mediated overexpression of miR-145 significantly improves cardiac function, reduces infarcted tissue size and prevents post-infarction induced apoptosis in rats after MI. Furthermore, PDCD4 was identified as a novel target of miR-145 in cardiomyocytes, and overexpression of PDCD4 could remarkably restore the miR-145-inhibited cardiomyocytes apoptosis and mitochondrial dysfunction after hypoxia injury. Therefore, our study indicated that miR-145/PDCD4 axis might be potential therapeutic targets for the treatment of MI, and its cardioprotective effect may be attributed to a reduction of mitochondria-mediated apoptosis.

Entities:  

Keywords:  Myocardial infarction; PDCD4; apoptosis; left anterior descending; microRNA-145; mitochondria

Year:  2017        PMID: 29218098      PMCID: PMC5714784     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction.

Authors:  Benjamin Meder; Andreas Keller; Britta Vogel; Jan Haas; Farbod Sedaghat-Hamedani; Elham Kayvanpour; Steffen Just; Anne Borries; Jessica Rudloff; Petra Leidinger; Eckart Meese; Hugo A Katus; Wolfgang Rottbauer
Journal:  Basic Res Cardiol       Date:  2010-10-01       Impact factor: 17.165

3.  Increased circulating mitochondrial DNA after myocardial infarction.

Authors:  Marte Bliksøen; Lars Henrik Mariero; Ingrid Kristine Ohm; Fred Haugen; Arne Yndestad; Svein Solheim; Ingebjørg Seljeflot; Trine Ranheim; Geir Øystein Andersen; Pål Aukrust; Guro Valen; Leif Erik Vinge
Journal:  Int J Cardiol       Date:  2012-05-10       Impact factor: 4.164

4.  Type 2 myocardial infarction in clinical practice.

Authors:  Tomasz Baron; Kristina Hambraeus; Johan Sundström; David Erlinge; Tomas Jernberg; Bertil Lindahl
Journal:  Heart       Date:  2014-10-20       Impact factor: 5.994

5.  Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury.

Authors:  Amadou K S Camara; Martin Bienengraeber; David F Stowe
Journal:  Front Physiol       Date:  2011-04-12       Impact factor: 4.566

6.  A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.

Authors:  Paola Caruso; Yvonne Dempsie; Hannah C Stevens; Robert A McDonald; Lu Long; Ruifang Lu; Kevin White; Kirsty M Mair; John D McClure; Mark Southwood; Paul Upton; Mei Xin; Eva van Rooij; Eric N Olson; Nicholas W Morrell; Margaret R MacLean; Andrew H Baker
Journal:  Circ Res       Date:  2012-06-19       Impact factor: 17.367

Review 7.  The role of microRNA in modulating myocardial ischemia-reperfusion injury.

Authors:  Yumei Ye; Jose R Perez-Polo; Jinqiao Qian; Yochai Birnbaum
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

8.  Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress.

Authors:  Lele Ji; Feng Fu; Lihua Zhang; Wenchong Liu; Xiaoqing Cai; Lei Zhang; Qiangsun Zheng; Haifeng Zhang; Feng Gao
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-02       Impact factor: 4.310

9.  Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats.

Authors:  Jiaqi Liu; Fei Sun; Yuying Wang; Wanqi Yang; Hongwen Xiao; Yue Zhang; Renzhong Lu; Haixia Zhu; Yuting Zhuang; Zhenwei Pan; Zhiguo Wang; Zhimin Du; Yanjie Lu
Journal:  Oncotarget       Date:  2017-03-21

10.  Circulating MicroRNA-145 is Associated with Acute Myocardial Infarction and Heart Failure.

Authors:  Ming Zhang; Yun-Jiu Cheng; Jaskanwal Ds Sara; Li-Juan Liu; Li-Ping Liu; Xin Zhao; Hai Gao
Journal:  Chin Med J (Engl)       Date:  2017 5th Jan 2017       Impact factor: 2.628

View more
  10 in total

Review 1.  Mitochondria and cardiovascular diseases-from pathophysiology to treatment.

Authors:  Gerasimos Siasos; Vasiliki Tsigkou; Marinos Kosmopoulos; Dimosthenis Theodosiadis; Spyridon Simantiris; Nikoletta Maria Tagkou; Athina Tsimpiktsioglou; Panagiota K Stampouloglou; Evangelos Oikonomou; Konstantinos Mourouzis; Anastasios Philippou; Manolis Vavuranakis; Christodoulos Stefanadis; Dimitris Tousoulis; Athanasios G Papavassiliou
Journal:  Ann Transl Med       Date:  2018-06

Review 2.  Mitochondrial microRNA (MitomiRs) in cancer and complex mitochondrial diseases: current status and future perspectives.

Authors:  Paresh Kumar Purohit; Neeru Saini
Journal:  Cell Mol Life Sci       Date:  2020-10-21       Impact factor: 9.261

3.  MicroRNA-145 plays a role in mitochondrial dysfunction in alveolar epithelial cells in -induced acute respiratory distress syndrome.

Authors:  Yi Han; Su-Cheng Mu; Jian-Li Wang; Wei Wei; Ming Zhu; Shi-Lin Du; Min Min; Yun-Jie Xu; Zhen-Ju Song; Chao-Yang Tong
Journal:  World J Emerg Med       Date:  2021

4.  The effect of eight weeks of moderate and high intensity aerobic training on the gene expression of Mir-145, Wnt3a and Dab2 in the heart tissue of type 2 diabetic rats.

Authors:  Sahar Rezaei; Asieh Abbassi Daloii; Alireza Barari; Mozhgan Ahmadi
Journal:  J Diabetes Metab Disord       Date:  2021-10-16

5.  lncRNA HOTAIR Protects Myocardial Infarction Rat by Sponging miR-519d-3p.

Authors:  Dongying Zhang; Bingjian Wang; Min Ma; Kun Yu; Qing Zhang; Xiwen Zhang
Journal:  J Cardiovasc Transl Res       Date:  2019-01-03       Impact factor: 4.132

6.  MiR-124 Regulates the Inflammation and Apoptosis in Myocardial Infarction Rats by Targeting STAT3.

Authors:  Xiao-Jing Cheng; Lei Li; Ben-Qiang Xin
Journal:  Cardiovasc Toxicol       Date:  2021-05-26       Impact factor: 3.231

7.  Over-expression of microRNA-145 drives alterations in β-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction.

Authors:  Zhebo Liu; Bo Tao; Suzhen Fan; Shengyu Cui; Yong Pu; Liqiang Qiu; Hao Xia; Lin Xu
Journal:  Aging (Albany NY)       Date:  2020-06-18       Impact factor: 5.682

8.  Long non-coding RNA MEG3 serves as a ceRNA for microRNA-145 to induce apoptosis of AC16 cardiomyocytes under high glucose condition.

Authors:  Yiwei Chen; Zhifang Zhang; Diqi Zhu; Wenchuo Zhao; Fen Li
Journal:  Biosci Rep       Date:  2019-06-07       Impact factor: 3.840

9.  Dexmedetomidine suppresses the development of abdominal aortic aneurysm by downregulating the mircoRNA‑21/PDCD 4 axis.

Authors:  Qi Yu; Qianqian Li; Xinglong Yang; Qiang Liu; Jun Deng; Yanping Zhao; Ruilin Hu; Min Dai
Journal:  Int J Mol Med       Date:  2021-03-31       Impact factor: 4.101

10.  CircularRNA circ_0071269 knockdown protects against from diabetic cardiomyopathy injury by microRNA-145/gasdermin A axis.

Authors:  Lanfang Fu; Juyun Zhang; Zhu Lin; Yi Li; Guijun Qin
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.